Aller au contenu principal
Profil bibliographique

Christopher P. Wardell

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

165Publications signalées
7795Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Multiple Myeloma Research and TreatmentsProtein Degradation and InhibitorsCancer Genomics and DiagnosticsPeptidase Inhibition and AnalysisGlycosylation and Glycoproteins Research

Les publications récentes

Accès ouvert 2026 preprint OpenAlex

Longitudinal multi-omics characterization of the malignant evolution in multirelapsing glioblastoma

Madeleine H. Lackman, Christopher P. Wardell, Emilie Darrigues, Annick De Loose et autres

Abstract Linking glioblastoma (GBM) evolution to clinical progression is challenged by multiple factors, including tumor location for repeated sample collection, and short patient survival. In a single individual, we collected and analysed samples from 11 operations distributed across 31 months of multi-relapsing …

fi, us (code pays fourni par la source)

0 citations medRxiv
2025 conference-abstract OpenAlex

Applying computational modelling to a high-risk multiple myeloma data set to create novel risk stratification groupings

Orthi Shahzad, Richard Norris, Niels Weinhold, Charlotte Pawlyn et autres

Abstract Introduction: Multiple Myeloma (MM) is a heterogeneous disease making it difficult to accurately predict the disease course in individual patients. Staging systems in MM have evolved, firstly the International Staging System (ISS), then incorporation of genomic aberrations with revised-ISS. Recently, the …

gb, es, de, us (code pays fourni par la source)

0 citations Blood
Accès ouvert 2025 article OpenAlex

Healing of lytic lesions and restoration of bone health in multiple myeloma through sclerostin inhibition

Hayley M. Sabol, Aric Anloague, Japneet Kaur, Cecile Bustamante-Gomez et autres

BACKGROUND: Multiple myeloma (MM) is associated with a debilitating bone disease that poses significant therapeutic challenges. MM bone disease is characterized by increased bone resorption and suppression of osteoblasts, which hinders the repair of damaged bone. Sclerostin, an antagonist of Wnt signaling, …

us, dk (code pays fourni par la source)

3 citations Experimental Hematology and Oncology
Accès ouvert 2024 article OpenAlex

Long-read sequencing for brain tumors

William J. Shelton, Sara Zandpazandi, James Stephen Nix, Murat Gökden et autres

Brain tumors and genomics have a long-standing history given that glioblastoma was the first cancer studied by the cancer genome atlas. The numerous and continuous advances through the decades in sequencing technologies have aided in the advanced molecular characterization of brain tumors …

us (code pays fourni par la source)

3 citations Frontiers in Oncology
2024 conference-abstract OpenAlex

Abstract 953: Integration of functional precision medicine assay for high grade glioma management: A single institution experience

Grace Guzman, Sahana Bettadapura, William Jeremy Shelton-Correa, Taylor Brooks et autres

Abstract Despite the advances in precision oncology, genomic approaches have not significantly improved outcomes for high grade gliomas (HGGs) as once was anticipated. Recurrent HGG pose even greater therapeutic challenge. The integration of functional precision medicine (FPM), in which drugs screens are …

us (code pays fourni par la source)

0 citations Cancer Research
Accès ouvert 2023 other OpenAlex

Data from Gender Disparities in the Tumor Genetics and Clinical Outcome of Multiple Myeloma

Kevin D. Boyd, Fiona M. Ross, Laura Chiecchio, Gian Paolo Dagrada et autres

Abstract Background: Several cancer types have differences in incidence and clinical outcome dependent on gender, but these are not well described in myeloma. The aim of this study was to characterize gender disparities in myeloma. Methods: We investigated the association of gender …

0 citations
Accès ouvert 2023 other OpenAlex

Data from Gender Disparities in the Tumor Genetics and Clinical Outcome of Multiple Myeloma

Kevin D. Boyd, Fiona M. Ross, Laura Chiecchio, Gian Paolo Dagrada et autres

Abstract Background: Several cancer types have differences in incidence and clinical outcome dependent on gender, but these are not well described in myeloma. The aim of this study was to characterize gender disparities in myeloma. Methods: We investigated the association of gender …

0 citations

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.